CDH3 and breast carcinoma: Based on the previous described anticancer and anti-migratory effects of azurin, we hypothesized that it could also be used as a therapeutic tool in highly aggressive breast cancers overexpressing P-cadherin, being able to inhibit its pro-invasive effects.